-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$219.13-10.02% Downside
Recent Analyst Forecasts and Stock Ratings
ResMed Inc. Frequently Asked Questions
-
What analysts cover ResMed Inc.?
ResMed Inc. has been rated by research analysts at RBC Capital, Robert W. Baird, Wolfe Research, Stifel Nicolaus, Oppenheimer, Needham in the past 90 days.